Company profile for Incyte Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Incyte's vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology. The field of oncology is evolving rapidly and transforming how cancer is and will be treated. With a growing pipeline that includes innovative compounds in three major oncology areas -- onco-inflammation, immuno-oncology and targeted...
Incyte's vision is to become a leading biopharmaceutical company by building a proprietary pipeline of novel small molecule drugs for serious unmet medical needs primarily in the area of oncology. The field of oncology is evolving rapidly and transforming how cancer is and will be treated. With a growing pipeline that includes innovative compounds in three major oncology areas -- onco-inflammation, immuno-oncology and targeted therapies -- we believe Incyte is at the center of this transformation in cancer care.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1801 Augustine Cut-off Wilmington, DE 19803
Telephone
Telephone
+1 1.855.446.2983
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251203376479/en/Global-Vitiligo-Foundation-Applauds-Partnership-Between-Incyte-and-Winnie-Harlow-to-Elevate-Awareness-and-Understanding-of-Vitiligo

BUSINESSWIRE
03 Dec 2025

https://www.fiercepharma.com/marketing/incyte-taps-winnie-harlow-model-vitiligo-awareness-empowerment-new-campaign

FIERCE PHARMA
02 Dec 2025

https://www.pharmiweb.com/press-release/2025-12-01/incyte-appoints-richard-hoffman-as-executive-vice-president-and-general-counsel

PHARMIWEB
01 Dec 2025

https://www.businesswire.com/news/home/20251119716031/en/Incyte-to-Present-at-Upcoming-Investor-Conferences

BUSINESSWIRE
19 Nov 2025

https://www.businesswire.com/news/home/20251116608532/en/Incyte-Announces-Positive-CHMP-Opinion-for-Minjuvi-tafasitamab-for-the-Treatment-of-Relapsed-or-Refractory-Follicular-Lymphoma-FL

BUSINESSWIRE
17 Nov 2025

https://www.businesswire.com/news/home/20251105709113/en/Incytes-Moments-of-Clarity-Program-Expands-to-Highlight-Powerful-Patient-Stories-in-Vitiligo-and-Pediatric-Eczema

BUSINESS WIRE
06 Nov 2025

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty